This company has been marked as potentially delisted and may not be actively trading. Medicis Pharmaceutical (MRX) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsDividendEarningsHeadlinesOptions ChainOwnershipTrendsBuy This Stock MRX vs. CBOE, BXP, CIB, FHN, SF, OHI, EVR, AFG, GL, and LINEShould you be buying Medicis Pharmaceutical stock or one of its competitors? The main competitors of Medicis Pharmaceutical include Cboe Global Markets (CBOE), BXP (BXP), BanColombia (CIB), First Horizon (FHN), Stifel Financial (SF), Omega Healthcare Investors (OHI), Evercore (EVR), American Financial Group (AFG), Globe Life (GL), and Lineage (LINE). These companies are all part of the "finance" sector. Medicis Pharmaceutical vs. Its Competitors Cboe Global Markets BXP BanColombia First Horizon Stifel Financial Omega Healthcare Investors Evercore American Financial Group Globe Life Lineage Medicis Pharmaceutical (NYSE:MRX) and Cboe Global Markets (NASDAQ:CBOE) are both finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, media sentiment, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation. Do insiders and institutionals hold more shares of MRX or CBOE? 82.7% of Cboe Global Markets shares are owned by institutional investors. 3.8% of Medicis Pharmaceutical shares are owned by company insiders. Comparatively, 0.2% of Cboe Global Markets shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has better earnings and valuation, MRX or CBOE? Cboe Global Markets has higher revenue and earnings than Medicis Pharmaceutical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedicis Pharmaceutical$1.24B2.18$141.30MN/AN/ACboe Global Markets$4.09B5.95$764.90M$7.6330.48 Does the media prefer MRX or CBOE? In the previous week, Cboe Global Markets had 17 more articles in the media than Medicis Pharmaceutical. MarketBeat recorded 17 mentions for Cboe Global Markets and 0 mentions for Medicis Pharmaceutical. Cboe Global Markets' average media sentiment score of 1.27 beat Medicis Pharmaceutical's score of 0.00 indicating that Cboe Global Markets is being referred to more favorably in the news media. Company Overall Sentiment Medicis Pharmaceutical Neutral Cboe Global Markets Positive Is MRX or CBOE more profitable? Cboe Global Markets has a net margin of 18.64% compared to Medicis Pharmaceutical's net margin of 0.00%. Cboe Global Markets' return on equity of 22.02% beat Medicis Pharmaceutical's return on equity.Company Net Margins Return on Equity Return on Assets Medicis PharmaceuticalN/A N/A N/A Cboe Global Markets 18.64%22.02%10.73% Do analysts rate MRX or CBOE? Medicis Pharmaceutical currently has a consensus target price of $44.00, indicating a potential upside of 13.86%. Cboe Global Markets has a consensus target price of $221.75, indicating a potential downside of 4.64%. Given Medicis Pharmaceutical's stronger consensus rating and higher probable upside, research analysts clearly believe Medicis Pharmaceutical is more favorable than Cboe Global Markets.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medicis Pharmaceutical 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.71Cboe Global Markets 3 Sell rating(s) 8 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.92 Is MRX or CBOE a better dividend stock? Medicis Pharmaceutical pays an annual dividend of $0.56 per share and has a dividend yield of 1.4%. Cboe Global Markets pays an annual dividend of $2.52 per share and has a dividend yield of 1.1%. Cboe Global Markets pays out 33.0% of its earnings in the form of a dividend. Cboe Global Markets has raised its dividend for 1 consecutive years. SummaryCboe Global Markets beats Medicis Pharmaceutical on 10 of the 16 factors compared between the two stocks. Get Medicis Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for MRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MRX vs. The Competition Export to ExcelMetricMedicis PharmaceuticalSecurity & commodity brokers IndustryFinance SectorNYSE ExchangeMarket Cap$2.73B$24.35B$11.87B$20.45BDividend Yield1.44%1.09%5.53%3.72%P/E RatioN/A16.1019.9727.80Price / Sales2.185.9525.7149.81Price / CashN/A19.4218.7218.22Price / BookN/A5.692.264.58Net Income$141.30M$764.90M$990.08M$982.91M Medicis Pharmaceutical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MRXMedicis Pharmaceutical0.6853 of 5 stars$38.65+18.8%$44.00+13.9%+99.4%$2.73B$1.24B0.002,074CBOECboe Global Markets3.013 of 5 stars$233.21+1.8%$219.64-5.8%N/A$24.42B$4.09B32.301,540Positive NewsAnalyst ForecastBXPBXP3.7149 of 5 stars$67.44-1.7%$79.54+17.9%+11.7%$10.86B$3.41B-3,370.31780News CoverageCIBBanColombia1.8541 of 5 stars$46.21+2.5%$39.00-15.6%+35.8%$10.84B$10.55B7.4134,114FHNFirst Horizon4.5878 of 5 stars$21.23+0.9%$22.53+6.1%+43.2%$10.67B$5.03B14.747,252Positive NewsAnalyst ForecastSFStifel Financial4.3659 of 5 stars$103.98+0.3%$105.50+1.5%+30.5%$10.65B$4.97B19.889,000Positive NewsAnalyst DowngradeOHIOmega Healthcare Investors4.4896 of 5 stars$36.63+0.1%$41.88+14.3%+7.7%$10.59B$1.05B22.7550Positive NewsEVREvercore3.9118 of 5 stars$270.85+0.7%$250.57-7.5%+33.4%$10.52B$2.98B25.922,380Analyst ForecastAFGAmerican Financial Group4.5737 of 5 stars$126.32+1.1%$139.33+10.3%+5.7%$10.45B$8.32B13.278,700GLGlobe Life4.6564 of 5 stars$124.43+0.4%$137.73+10.7%+48.7%$10.23B$5.78B10.123,732Analyst ForecastLINELineage4.523 of 5 stars$43.52-1.3%$62.10+42.7%N/A$10.08B$5.34B-13.5226,000 Related Companies and Tools Related Companies CBOE Competitors BXP Competitors CIB Competitors FHN Competitors SF Competitors OHI Competitors EVR Competitors AFG Competitors GL Competitors LINE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MRX) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredNobel Prize Material Finally Goes CommercialA Nobel Prize–winning material just got its biggest breakthrough in 30 years. A little-known company has cr...True Market Insiders | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicis Pharmaceutical Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicis Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
